DarioHealth Corp. (DRIO) is a Healthcare stock trading at $7.00 (as of 2026-06-18), with a market capitalization of $56.67M and a trailing P/E of 0.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
DarioHealth Corp. is a digital therapeutics company offering technology-enabled programs and associated devices for health management across multiple conditions. Its offerings include metabolic, musculoskeletal, behavioral health, and chronic condition solutions, plus a care management platform and test-related consumables and monitoring devices for users in the U.S., Canada, the EU, Australia, and New Zealand.